Organogenesis Holdings Inc.
ORGO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661181
No open-market purchases or sales by Organogenesis Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $160.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Organogenesis Holdings Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 136
- +17 vs. Q4 2024
- Shares held
- 64.9M
- +2.72M (+4.4%) vs. Q4 2024
- Total value
- $280.6M
- +$81.5M (+40.9%) vs. Q4 2024
- New holders
- 28
- 45 more added
- Sold out
- 11
- 46 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORGO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $160.4M |
| Q1 2026 | 121 | $146.8M |
| Q4 2025 | 147 | $359.8M |
| Q3 2025 | 121 | $288.5M |
| Q2 2025 | 116 | $253.9M |
| Q1 2025 | 136 | $280.6M |
| Q4 2024 | 120 | $200.2M |
| Q3 2024 | 112 | $183.0M |
| Q2 2024 | 116 | $176.6M |
| Q1 2024 | 124 | $162.0M |
| Q4 2023 | 108 | $238.3M |
| Q3 2023 | 105 | $167.2M |
| Q2 2023 | 113 | $171.8M |
| Q1 2023 | 132 | $113.8M |
| Q4 2022 | 150 | $150.6M |
| Q3 2022 | 154 | $178.2M |
| Q2 2022 | 147 | $283.3M |
| Q1 2022 | 156 | $441.0M |
| Q4 2021 | 157 | $515.7M |
| Q3 2021 | 153 | $763.1M |
| Q2 2021 | 142 | $830.0M |
| Q1 2021 | 101 | $453.1M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Organogenesis Holdings Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 236,730 | $1.02M | 0.00% | −19,071−7.5% | Reduced |
| FMR LLC | 237,663 | $1.03M | 0.00% | −5,815−2.4% | Reduced |
| Wellington Management Group LLP | 245,548 | $1.06M | 0.00% | −8,734−3.4% | Reduced |
| State of Wisconsin Investment Board | 263,674 | $1.14M | 0.00% | +81,007+44.3% | Added |
| Qube Research & Technologies Ltd | 287,768 | $1.24M | 0.00% | +184,692+179.2% | Added |
| JPMorgan Chase & Co | 304,312 | $1.31M | 0.00% | +23,315+8.3% | Added |
| Two Sigma Investments, LP | 325,014 | $1.40M | 0.00% | −57,392−15.0% | Reduced |
| Los Angeles Capital Management LLC | 335,970 | $1.45M | 0.01% | +11,959+3.7% | Added |
| Assenagon Asset Management S.A. | 336,963 | $1.46M | 0.00% | −2,613,886−88.6% | Reduced |
| UBS Group AG | 345,658 | $1.49M | 0.00% | +288,762+507.5% | Added |
| Two Sigma Advisers, LP | 357,500 | $1.54M | 0.00% | −131,500−26.9% | Reduced |
| Bank of New York Mellon Corp | 378,002 | $1.63M | 0.00% | −40,818−9.7% | Reduced |
| Wealth Dimensions Group, Ltd. | 407,965 | $1.76M | 0.42% | 00.0% | Unchanged |
| Raymond James Financial Inc | 420,321 | $1.82M | 0.00% | +420,321 | New |
| Goldman Sachs Group Inc | 422,030 | $1.82M | 0.00% | −234,126−35.7% | Reduced |
| Norges Bank | 482,200 | $2.08M | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 501,028 | $2.16M | 0.00% | −18,086−3.5% | Reduced |
| SG Americas Securities, LLC | 525,421 | $2.27M | 0.01% | +483,675+1,158.6% | Added |
| Northern Trust Corp | 593,393 | $2.56M | 0.00% | −22,696−3.7% | Reduced |
| Lazard Asset Management LLC | 649,384 | $2.81M | 0.00% | +477,690+278.2% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 667,529 | $2.88M | 0.01% | +208,038+45.3% | Added |
| Charles Schwab Investment Management Inc | 835,046 | $3.61M | 0.00% | −90,614−9.8% | Reduced |
| D. E. Shaw & Co., Inc. | 884,288 | $3.82M | 0.00% | +146,845+19.9% | Added |
| AQR Capital Management LLC | 893,767 | $3.86M | 0.00% | −628,387−41.3% | Reduced |
| Renaissance Technologies LLC | 1,043,500 | $4.51M | 0.01% | −30,000−2.8% | Reduced |
| Invesco Ltd. | 1,069,252 | $4.62M | 0.00% | +947,705+779.7% | Added |
| Geode Capital Management, LLC | 1,703,876 | $7.36M | 0.00% | −33,880−1.9% | Reduced |
| Driehaus Capital Management LLC | 1,795,347 | $7.76M | 0.07% | +1,795,347 | New |
| State Street Corp | 1,940,877 | $8.38M | 0.00% | +386,366+24.9% | Added |
| Acadian Asset Management LLC | 2,333,245 | $10.1M | 0.03% | −751,458−24.4% | Reduced |
| Deutsche Bank AG | 2,441,902 | $10.5M | 0.00% | −7,933−0.3% | Reduced |
| Dimensional Fund Advisors LP | 3,100,396 | $13.4M | 0.00% | +311,131+11.2% | Added |
| Vanguard Group Inc | 4,431,414 | $19.1M | 0.00% | +841,618+23.4% | Added |
| BlackRock, Inc. | 5,156,403 | $22.3M | 0.00% | −119,618−2.3% | Reduced |
| Morgan Stanley | 12,115,975 | $52.3M | 0.00% | +285,398+2.4% | Added |
| Soleus Capital Management, L.P. | 12,478,351 | $53.9M | 4.23% | −6,525−0.1% | Reduced |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −354,154−100.0% | Sold out |
| Savant Capital, LLC | 0 | $0 | 0.00% | −64,623−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −56,408−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −49,000−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Estabrook Capital Management | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −4,260−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −2,311−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −1,001−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −705−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |